Acne VulgarisNCT01050465
MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use
A study testing health information prescription in people with Acne Vulgaris and Allergic Rhinitis, run by University of Missouri-Columbia.
Trial summary
The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Acne Vulgaris, Allergic Rhinitis, Anxiety
- What is being tested?
- health information prescription
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 907 participants
- Where
- No sites listed yet
- Study dates
- May 2009to Dec 2010
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- one of the 40 target health conditions.
Who cannot join
- absence of at least one of the target 40 conditions
About this study
Official title: MedlinePlus Health Prescriptions: Developing a Real World Approach for Clinic Use
The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.
Read the detailed description
The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.
Primary Hypothesis. Individuals in the paper prescription group will be just as likely to seek information using MedlinePlus compared with individuals in the group who receive the same customized information through an email prescription.
Secondary Hypothesis. Individuals in the paper prescription group will be just as likely to have successful behavioral outcome measures as those in the group who receive the same customized information through an email prescription.
- Conditions
- Acne Vulgaris, Allergic Rhinitis, Anxiety, Asthma, Back Pain, Prostatic Hyperplasia
- Being tested
- health information prescription
- Keywords
- HIV, Knee pain, Colonoscopy, Mammography, Vaccination
- Medical subject headings
- Acne Vulgaris, Rhinitis, Allergic, Anxiety Disorders, Asthma, Back Pain, Prostatic Hyperplasia, Bursitis, Pulmonary Disease, Chronic Obstructive
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
health information prescriptionOther
Patients randomized to the email arm will receive a health information prescription via email on a health care topic following their clinic visit. Patients randomized to the paper arm will receive a health information prescription on paper on a health care topic following their clinic visit.
| Study group | Role | What they receive |
|---|---|---|
| Active comparator | Patients randomized to this arm will receive an email health information prescription. Receives: Other: health information prescription | |
| paper | Active comparator | Patients randomized to this arm will receive a paper health information prescription. Receives: Other: health information prescription |
What is being measured
The primary outcome is the main question the study is designed to answer.
seeking information using MedlinePlus
Measured: clicks will be tracked on the website when they occur
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jan 2010 (estimated)
- Study startMay 2009
- Primary completionOct 2010
- Study completionDec 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Acne VulgarisStudies of the same condition, open and under way.
- More trials run by University of Missouri-ColumbiaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 907 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Missouri-Columbia
- Sponsor type
- University, hospital or other
- Collaborators
- National Library of Medicine (NLM)
- Responsible party
- Sponsor
- Investigators
- Robert Hodge, MD, Principal investigator, University of Missouri-Columbia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01050465
- Sponsor's protocol ID
- HHSN276200800445P
- Status last verified
- Sep 2016
- First submitted
- 13 Jan 2010
- Last updated
- 30 Sep 2016
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
Coberly E, Boren SA, Mittal M, Davis JW, Scoville C, Chitima-Matsiga R, Ge B, Cullina A, Logan RA, Steinmann WC, Hodge RH. MedlinePlus-based health information prescriptions: a comparison of email vs paper delivery. Inform Prim Care. 2012;20(3):197-205. doi: 10.14236/jhi.v20i3.25.
PubMed 23710844
Study at a glance
From the registry record, last updated by the sponsor on 30 Sep 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- MedlinePlus Health Prescriptions: Developing a Real World Approach for Clinic Use
- ClinicalTrials.gov ID
- NCT01050465
- Acronym / sponsor ID
- HHSN276200800445P
- Conditions
- Acne Vulgaris, Allergic Rhinitis, Anxiety, Asthma, Back Pain, Prostatic Hyperplasia
- Keywords
- HIV, Knee pain, Colonoscopy, Mammography, Vaccination
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 907 participants (actual)
- Lead sponsor
- University of Missouri-ColumbiaUniversity, hospital or other
- Collaborators
- National Library of Medicine (NLM)
- Study start
- May 2009
- Primary completion
- Oct 2010 (actual)
- Study completion
- Dec 2010 (actual)
- First posted
- 15 Jan 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.
Detailed description
The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.
Primary Hypothesis. Individuals in the paper prescription group will be just as likely to seek information using MedlinePlus compared with individuals in the group who receive the same customized information through an email prescription.
Secondary Hypothesis. Individuals in the paper prescription group will be just as likely to have successful behavioral outcome measures as those in the group who receive the same customized information through an email prescription.
Study design
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Active comparator | Other: health information prescriptionPatients randomized to this arm will receive an email health information prescription. | |
| paper | Active comparator | Other: health information prescriptionPatients randomized to this arm will receive a paper health information prescription. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- one of the 40 target health conditions.
Key exclusion criteria (1 listed)
- absence of at least one of the target 40 conditions
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| health information prescriptionPatients randomized to the email arm will receive a health information prescription via email on a health care topic following their clinic visit. Patients randomized to the paper arm will receive a health information prescription on paper on a health care topic following their clinic visit. | Other | email, paper |
Primary outcome
seeking information using MedlinePlus
Time frame: clicks will be tracked on the website when they occur
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Sep 2016.
- Derived from this study: PubMed 23710844Coberly E, Boren SA, Mittal M, Davis JW, Scoville C, Chitima-Matsiga R, Ge B, Cullina A, Logan RA, Steinmann WC, Hodge RH. MedlinePlus-based health information prescriptions: a comparison of email vs paper delivery. Inform Prim Care. 2012;20(3):197-205. doi: 10.14236/jhi.v20i3.25.
- Individual participant dataSharing planned: No
Related trials for Acne Vulgaris
Not yet recruitingPhase 3
Evaluation of the Efficacy and Safety of Fractional CO₂ Laser With and Without Intradermal Botulinum Toxin A in the Treatment of Inflammatory Facial Acne Vulgaris.
Acne, Acne Papulopustulosa
RecruitingPhase 4
Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris
Acne
RecruitingPhase 3
Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)
Acne Vulgaris
RecruitingPhase 4
Comparing Nadifloxacin Plus Tretinoin Versus Clindamycin Plus Tretinoin Creams for Mild-to-Moderate Acne
Acne Vulgaris
Active, not recruiting
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
Hair Reduction, Tattoo Removal
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Robert Hodge, MD principal investigator
University of Missouri-Columbia
Questions about this trial
What is this clinical trial studying?
A study testing health information prescription in people with Acne Vulgaris and Allergic Rhinitis, run by University of Missouri-Columbia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
seeking information using MedlinePlus (time frame: clicks will be tracked on the website when they occur). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01050465, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2016.